Le Lézard
Classified in: Health
Subject: PDT

dG Medical Group Unveils "Genesis PDPA: Cell Factors": A Revolutionary Leap in Regenerative Medicine


dG Medical Group, an innovator in regenerative healthcare solutions, is proud to announce the launch of Genesis PDPA, marking a significant advancement in the field of regenerative medicine.

CLEARWATER, Fla., July 2, 2024 /PRNewswire-PRWeb/ -- Genesis PDPA (Placentally Derived Protein Arrays) is a groundbreaking product that represents the culmination of cutting-edge research in developmental biology and harnessing the power of messaging cell factors. These PDPA cell factors are believed to be an order of magnitude more potent than existing therapies, potentially offering unparalleled capabilities in promoting tissue regeneration and anti-aging capabilities.

Our mission extends beyond the laboratory, into creating products that positively contribute to society and individual's lives while adhering to the highest ethical standards in the industry.

A New Era of Treatment

Genesis PDPA introduces an era of enhanced regenerative capabilities, offering hope and new possibilities for providing advanced therapeutic options to physicians, athletes, and everyday patients. Due to its effectiveness in accelerating recovery, alleviation of symptoms, and returning patients back to a higher quality of life, Genesis PDPA is rapidly becoming a preferred regenerative and anti-aging treatment option.

Commitment to Ethical & Safe Innovation

Donor tissue for Genesis PDPA is ethically collected from consenting patients with a proven clean health history, by licensed tissue banks using current good tissue practices (CGTP), tested negative for communicable disease by FDA/CLIA certified labs, and every lot is endotoxin tested to ensure the highest of purity. Genesis PDPA is manufactured via a proprietary process that yields an acellular, non-biologic product for maximum patient safety.

"Our mission extends beyond the laboratory, into creating products that positively contribute to society and individual's lives while adhering to the highest ethical standards in the industry," stated Michael Major, President of dG Medical Group.

Learn More About Genesis PDPA

We invite both healthcare professionals, as well as patients, to learn more about this innovative and powerful therapy at www.dgmedicalgroup.com. If you'd like to get a consult with a healthcare professional currently offering Genesis PDPA, click on "Find A Genesis Provider." If you are a healthcare provider wanting to learn more and potentially offer Genesis PDPA to your patients, click on "Become a Genesis Provider."

About dG Medical Group

dG Medical Group specializes in the development and distribution of advanced regenerative medicine products. With a focus on ethical research and interdisciplinary collaboration, dG Medical Group is dedicated to improving quality of life and advancing the field of healthcare.

Contact:

Public Relations Office

dG Medical Group

Email: [email protected]

Phone: +1 (855) 320-7559

Media Contact

Mike Major, D & G Medical Group, Inc, 1 (855) 320-7559, [email protected], https://dgmedicalgroup.com

SOURCE D & G Medical Group, Inc


These press releases may also interest you

at 15:04
/C O R R E C T I O N -- Menarini Silicon Biosystems/
In the news release, Menarini's cell based non-invasive prenatal technology demonstrates high resolution detection of fetal genomic abnormalities from a simple maternal blood draw, issued 02-Jul-2024 by Menarini Silicon Biosystems over PR Newswire,...

at 14:53
Alzheimer's Association Welcomes U.S. FDA Approval of Kisunla (donanemab)
The Alzheimer's Association celebrates today's U.S. Food and Drug Administration (FDA) action to approve Kisunlatm (donanemab, Eli Lilly) for the treatment of people living with early symptomatic Alzheimer's disease, which includes mild cognitive...

at 14:45
Alleva Recognized in Software Advice FrontRunners for HIPAA Compliance Software Report 2024
Alleva, a premier provider of electronic medical record (EMR) software solutions tailored for the behavioral health and addiction recovery sectors, is proud to announce its inclusion in the Software Advice FrontRunners for HIPAA Compliance Software...

at 14:37
The Association for Diagnostics & Laboratory Medicine (formerly AACC) supports Rep. Cassidy's letter asking the FDA to explain how it plans to abide by the recent Supreme Court decision curtailing the power of federal agencies
Statement attributable to:Octavia Peck Palmer, PhDPresident, Association for Diagnostics & Laboratory Medicine (formerly AACC) "On June 28, in Loper Bright Enterprises v. Raimondo, the Supreme Court overturned the so-called Chevron doctrine and...

at 14:24
NanoCellect Launches VERLO: First Demonstration of Image-Based Sorting of Interacting Immune Synapsed Cells Followed by Confirmation of Immune Functionality
NanoCellect Biomedical, a leader in microfluidic cell sorting technology, proudly announces the launch of VERLOtm Image-Guided Cell Sorter, a groundbreaking cell sorter poised to redefine the landscape of single-cell visualization and gentle flow...

at 14:00
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders, announced today...

More news about Health...


News published on and distributed by: